Dexcom | DXCM - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
60.95
Cambio Giornaliero
1.40 2.35%
Mensile
-2.04%
Annuale
-25.32%
Q2 Previsione
60.25




Spese Di Vendita E Di Amministrazione Cambiamento Data
Abbott USD 3.27B 138M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 110.47M 4.36M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
West Pharmaceutical Services USD 99.5M 7M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03